MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2022 International Congress

    Impact of the dopamine system on long-term, incident cognitive impairment in Parkinson disease

    D. Weintraub, M. Picillo, H. Cho, C. Caspell-Garcia, C. Coffey, K. Marek, K. Poston, T. Simuni, J. Seibyl, A. Siderowf, A. Singleton, C. Tanner (Philadelphia, USA)

    Objective: To determine the impact of the dopamine system (dopamine transporter [DAT] availability, dopamine-related SNPs, and dopaminergic medication use) on long-term cognitive performance in early…
  • 2022 International Congress

    Boostering motor imagery processing to improve gait in patients with Parkinson disease and freezing of gait: a preliminary study

    S. Mezzarobba, E. Ravizzotti, P. Bernardis, M. Putzolu, C. Cosentino, A. Botta, G. Bonassi, R. Marchese, L. Avanzino, E. Pelosin (Genoa, Italy)

    Objective: The aim of this study is to evaluate the priming effect of visual, auditory and cognitive tasks in enhancing Motor Imagery (MI) ability in…
  • 2022 International Congress

    Huntington’s Disease, Cognition, and Fear of Falling

    A. Sethi, S. Baek, O. Kaczmarek, B. Bumstead, M. Buhse, M. Zarif, M. Gudesblatt (Patchogue, USA)

    Objective: Explore the relationship of cognition and patient-reported assessment on fear of falling in people with Huntington’s Disease. Background: Huntington’s Disease (HD) is a relentlessly…
  • 2022 International Congress

    Longitudinal predictors of functional dependence in a multicentric Parkinson’s Disease cohort

    S. Becker, B. Callahan (Calgary, Canada)

    Objective: To explore clinical and cognitive predictors of functional dependence in a cohort of early Parkinson’s Disease (PD) patients. Background: Parkinson’s Disease (PD) patients are…
  • 2022 International Congress

    A Useful Cognitive-Motor Dual Task Paradigm in Prodromal and Manifest HD

    EG. Churchill, J. Corey-Bloom, A. Hall, C. Snell, A. Smirnova, SB. Hughes, PE. Gilbert, DJ. Goble (San Diego, USA)

    Objective: To investigate whether a cognitive-motor dual task (DT) paradigm uncovers deficits in balance in Huntington’s disease (HD) and, more importantly, prodromal HD, compared to…
  • 2022 International Congress

    Late Onset Ataxia, Myoclonus, and Cognitive Decline in a Patient with Xeroderma Pigmentosum: A Case Report

    J. Modica, A. Hewitt, P. Morrison (Rochester, USA)

    Objective: To present a case of late onset neurologic symptoms of ataxia, myoclonus, and cognitive impairment in a 37-year-old man with xeroderma pigmentosum (XP). Background:…
  • 2022 International Congress

    Influence of alcohol consumption on cognitive decline in Parkinson disease.

    E. Ruiz-Fernández, J. Marín-Lahoz, J. Pagonabarraga, A. Horta-Barba, S. Martínez-Horta, H. Bejr-Kasem, I. Aracil-Bolaños, A. Campolongo, J. Kulisevsky (Zaragoza, Spain)

    Objective: To assess whether alcohol consumption (AC) is independently associated with cognitive decline (CD) in PD. Background: AC is linked to dementia and neurological damage…
  • 2022 International Congress

    Robust methods for missing covariates in longitudinal studies with application to biomarker research in Parkinson’s disease dementia

    L. Suttner, P. Zhang, S. Xie (Philadelphia, USA)

    Objective: We propose a nonparametric method for handling different types of missing covariates in longitudinal studies. We show that the proposed method outperforms multiple standard…
  • 2022 International Congress

    A randomized clinical trial (RCT) to evaluate the effects of safinamide on apathetic non-demented Parkinson’s disease patients

    J. Kulisevsky, S. Martinez-Horta, A. Campolongo, B. Pascual-Sedano, J. Marin-Lahoz, H. Bejr-Kasem, A. Horta-Barba, A. Puig-Davi, J. Pagonabarraga, I. Aracil-Bolaños, J. Rodriguez-Antiguedad (Barcelona, Spain)

    Objective: To evaluate the safety and effects of add-on safinamide on apathy in patients with Parkinson’s disease (PD). Background: Apathy is highly prevalent and disabling…
  • 2022 International Congress

    The effect of Deep Brain Stimulation on Sense of agency in Parkinson’s disease patients with and without impulsive compulsive behaviours.

    L. Ricciardi, A. de Angelis, MP. Stenner, F. Baig, E. Pereira, S. Di Costa, MJ. Edwards, P. Haggard, F. Morgante (London, United Kingdom)

    Objective: To evaluate the effect of Deep Brain stimulation of the Subthalamic Nucleus (STN-DBS) on sense of agency in PD patients undergoing DBS; To look…
  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley